Janney Montgomery Scott LLC - KEMPHARM INC ownership

KEMPHARM INC's ticker is KMPH and the CUSIP is 488445206. A total of 61 filers reported holding KEMPHARM INC in Q1 2023. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.

Quarter-by-quarter ownership
Janney Montgomery Scott LLC ownership history of KEMPHARM INC
ValueSharesWeighting
Q3 2023$3,250
+21.9%
674,369
+29.0%
0.01%
+33.3%
Q2 2023$2,666
-8.3%
522,770
-1.1%
0.01%
-25.0%
Q1 2023$2,908
+28.2%
528,755
+7.0%
0.01%
+33.3%
Q4 2022$2,268
-99.9%
494,030
+3.1%
0.01%
-30.8%
Q3 2022$2,991,000
+38.1%
479,380
+0.0%
0.01%
+30.0%
Q2 2022$2,166,000
+23.0%
479,220
+36.9%
0.01%
+25.0%
Q1 2022$1,761,000
-29.3%
350,120
+22.5%
0.01%
-20.0%
Q4 2021$2,490,000
-4.5%
285,915
+2.3%
0.01%
-9.1%
Q3 2021$2,607,000
-21.4%
279,440
+8.0%
0.01%
-26.7%
Q2 2021$3,316,000
+2834.5%
258,665
+2003.0%
0.02%
+1400.0%
Q1 2021$113,00012,3000.00%
Other shareholders
KEMPHARM INC shareholders Q1 2023
NameSharesValueWeighting ↓
Retirement Planning Co of New England, Inc. 327,583$1,801,7071.09%
Mystic Asset Management, Inc. 177,533$976,4320.54%
GREAT POINT PARTNERS LLC 347,824$1,913,0320.38%
Kovack Advisors, Inc. 122,822$675,5210.09%
City State Bank 14,224$780.04%
Arete Wealth Advisors, LLC 82,290$4530.04%
VisionPoint Advisory Group, LLC 10,217$49,8590.02%
Laurion Capital Management LP 571,200$3,141,6000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 95,143$523,2870.01%
Janney Montgomery Scott LLC 528,755$2,9080.01%
View complete list of KEMPHARM INC shareholders